|
Mar 11
|
Exploring Three High Growth Tech Stocks In Australia
|
|
Mar 10
|
Opthea Limited (OPT): Among the Best Australian Stocks to Buy According to Billionaires
|
|
Feb 26
|
Opthea Completes Drug Product PPQ Campaign
|
|
Feb 18
|
Opthea Completes COAST Final Week 52 Patient Visit
|
|
Sep 30
|
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
|
|
Jul 9
|
Opthea Announces Publication on VEGF-C and D Signaling Pathways as Potential Targets for Treatment of Wet AMD
|
|
Jun 19
|
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
|
|
Jun 13
|
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
|
|
Dec 27
|
Opthea to Receive US$35M Commitment and Additional US$50M Funding
|
|
Dec 19
|
Opthea Receives A$8.8 million R&D Tax Incentive
|
|
Dec 1
|
Opthea to Present at the FLORetina 2023 Congress
|
|
Sep 7
|
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
|
|
Jul 10
|
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
|